Open Access Policy

Pharmaceutical and Clinical Journal of Nasri (PCJN) publishes fully open access content. All articles published in this journal are made freely available online immediately upon publication, allowing readers to access, read, download, and share the content without financial, legal, or technical barriers.

Non-commercial use, distribution, and reproduction in any medium are permitted, provided that the original author(s) and the journal are properly credited.

This open access policy is based on the principle that making scientific research freely available to the public supports a broader global exchange of knowledge and enhances the dissemination of scientific information.

Benefits of Open Access for Authors

Publishing in an open access journal provides several advantages for authors, including:

1. Free and immediate access for readers worldwide
2. Authors retain copyright of their work
3. Greater visibility and readership of published articles
4. Faster dissemination of research findings
5. No restrictions on article length or spatial limitations

Through this open access model, the journal aims to increase the accessibility, visibility, and impact of scholarly research within the pharmaceutical and clinical sciences community.